In: PATENT NEWS
Novartis defeats challenge to validity of Afinitor patent Reuters (Reuters) – Novartis scored a win in litigation over one of the patents underlying its cancer treatment Afinitor, as a federal appeals court on Monday rejected …
In: PATENT NEWS
Brainstorm Health: AliveCor ECG, Bayer Roundup Trial, AbbVie Patent Fortune Good afternoon, readers. Zebra Medical Vision, an Israel-base digital health company (whose co-founder and CEO Eyal Gura was featured at our Brainstorm …
In: PATENT NEWS
An Uptick In Patents From Historically Black Colleges Fortune According to research from ThePLUG, the number of patents held by HBCUs has increased since 2010.
In: PATENT NEWS
US Patent Office Rules on 3 Motorola Patents RadioResource Media Group By Danny Ramey, Web Editor. Tuesday, May 14, 2019 | Comments. The U.S. Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) …
In: PATENT NEWS
New Sony patents could be PlayStation’s answer to Google Stadia Digital Trends Google Stadia will be attempting to cut into the pie dominated by Sony, Microsoft, and Nintendo later this year but one of its competitors may already have an …
In: PATENT NEWS
AbbVie, Boehringer Settle U.S. Patent Dispute Over Drug Humira The Wall Street Journal AbbVie and Boehringer Ingelheim said they have resolved their U.S. patent dispute over a biosimilar to Abbvie’s Humira, the world’s biggest-selling drug.
In: PATENT NEWS
Qualcomm Signs 5G Global Patent License Deal With HMD Global Nasdaq Qualcomm Incorporated QCOM recently announced that it has reached a direct global license agreement with HMD Global Oy to cover Nokia branded.
In: PATENT NEWS
Patent Trends Study Part Ten: Artificial Intelligence Industry IPWatchdog.com In part nine of our patent trends study, we discussed the emerging blockchain industry. Today, we turn to artificial intelligence (AI).
In: PATENT NEWS
Digital Ally and WatchGuard Reach a Resolution of their Pending Patent Infringement Litigation Yahoo Finance The Parties Execute a Patent License and Settlement Agreement Resulting in the Dismissal of the Litigation with Prejudice. Lenexa, KS, May 14, 2019 (GLOBE …
In: PATENT NEWS
New Velcade rival, looming Uloric patent loss will cost post-Shire Takeda growth: CEO FiercePharma Takeda, in its first year counting the Shire business, has managed to turn up revenue growth. But the upcoming fiscal year could be a different story.
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION